e-learning
resources
Munich 2006
Sunday 03.09.2006
Markers of paediatric airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled nitric oxide levels in infants at the age of 6 weeks and 6 months: a prospective birth cohort study
E. Van Mastrigt, C. Gabriele, V. Jaddoe, H. A. Moll, A. Hofman, J. C. de Jongste (Rotterdam, Netherlands)
Source:
Annual Congress 2006 - Markers of paediatric airway disease
Session:
Markers of paediatric airway disease
Session type:
Oral Presentation
Number:
792
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Van Mastrigt, C. Gabriele, V. Jaddoe, H. A. Moll, A. Hofman, J. C. de Jongste (Rotterdam, Netherlands). Exhaled nitric oxide levels in infants at the age of 6 weeks and 6 months: a prospective birth cohort study. Eur Respir J 2006; 28: Suppl. 50, 792
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Measurements of exhaled nitric oxide in healthy subjects age 5 to 14 years
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006
Infant exhaled nitric oxide does not identify wheezy children by age of seven years
Source: Annual Congress 2010 - Paediatric asthma risk factors
Year: 2010
The relationship between exhaled nitric oxide measurements and subsequent asthma control in a cohort of children followed over 12-months
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
Fraction of exhaled nitric oxide in children aged 4 to 11 years
Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange
Year: 2012
Exhaled nitric oxide (eNO)
versus
spirometry in a cohort of school aged children
Source: Eur Respir J 2005; 26: Suppl. 49, 41s
Year: 2005
Infant exhaled nitric oxide does not identify persistent wheezers by the age of four years
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
Outcomes following the use of inhaled nitric oxide rescue therapy in preterm infants less than 30 weeks gestation
Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Year: 2020
Smoke exposure, airway symptoms and exhaled nitric oxide in infants: the Generation R study
Source: Eur Respir J 2008; 32: 307-313
Year: 2008
The cost and benefits of exhaled nitric oxide (NO) measurement in asthma - The results from three years follow-up study
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Feasibility and normal values of exhaled nitric oxide in healthy children and adolescence between 4 – 17 years measured with NIOX™
Source: Eur Respir J 2003; 22: Suppl. 45, 568s
Year: 2003
The change in exhaled nitric oxide in adolescents – a longitudinal cohort study
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Association of wheezing phenotypes in the first 7 years of life with fractional exhaled nitric oxide and lung function in adolescence. The ALSPAC study
Source: Annual Congress 2011 - Early wheezing conditions in childhood
Year: 2011
Fractional exhaled nitric oxide (FeNO), Impulse Oscilometry (IOS) and clinical status in 4 to 7 years old asthmatic children
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
By how much can exhaled nitric oxide vary over three months in children with stable asthma?
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study
Source: Eur Respir J 2012; 39: 567-572
Year: 2012
Reference values of exhaled nitric oxide in healthy Asian children aged 5 to 18 years
Source: Eur Respir J 2012; 39: 378-384
Year: 2012
Predictive value of exhaled nitric oxide in healthy infants for asthma at school age
Source: Eur Respir J 2016; 48: 925-928
Year: 2016
Predictors of exhaled nitric oxide (F
ENO
) in a large population-based sample of schoolchildren
Source: Eur Respir J 2007; 30: Suppl. 51, 724s
Year: 2007
Exhaled nitric oxide is elevated in young preschool children with persistent asthma at school age
Source: Annual Congress 2008 - Preschool wheezing: advances in diagnosis, phenotyping and therapy
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept